DZ Bank’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-2,361
| Closed | -$529K | – | 1024 |
|
2025
Q1 | $529K | Buy |
2,361
+500
| +27% | +$112K | ﹤0.01% | 723 |
|
2024
Q4 | $610K | Sell |
1,861
-3,774
| -67% | -$1.24M | ﹤0.01% | 696 |
|
2024
Q3 | $1.69M | Sell |
5,635
-24,781
| -81% | -$7.44M | ﹤0.01% | 573 |
|
2024
Q2 | $10M | Sell |
30,416
-30,454
| -50% | -$10M | 0.01% | 329 |
|
2024
Q1 | $24.1M | Buy |
60,870
+57,811
| +1,890% | +$22.9M | 0.03% | 218 |
|
2023
Q4 | $1.08M | Sell |
3,059
-4,748
| -61% | -$1.67M | ﹤0.01% | 626 |
|
2023
Q3 | $2.93M | Buy |
7,807
+155
| +2% | +$58.2K | ﹤0.01% | 493 |
|
2023
Q2 | $2.93M | Buy |
7,652
+4,798
| +168% | +$1.84M | ﹤0.01% | 517 |
|
2023
Q1 | $989K | Buy |
+2,854
| New | +$989K | ﹤0.01% | 660 |
|
2022
Q4 | – | Sell |
-52
| Closed | -$13K | – | 1186 |
|
2022
Q3 | $13K | Sell |
52
-2,952
| -98% | -$738K | ﹤0.01% | 1070 |
|
2022
Q2 | $908K | Buy |
+3,004
| New | +$908K | ﹤0.01% | 710 |
|
2021
Q3 | – | Sell |
-2,434
| Closed | -$874K | – | 1087 |
|
2021
Q2 | $874K | Sell |
2,434
-26,952
| -92% | -$9.68M | ﹤0.01% | 689 |
|
2021
Q1 | $8.28M | Buy |
29,386
+27,644
| +1,587% | +$7.79M | 0.02% | 358 |
|
2020
Q4 | $493K | Sell |
1,742
-2,758
| -61% | -$781K | ﹤0.01% | 677 |
|
2020
Q3 | $1.24M | Buy |
4,500
+4,016
| +830% | +$1.1M | ﹤0.01% | 512 |
|
2020
Q2 | $109K | Buy |
+484
| New | +$109K | ﹤0.01% | 734 |
|
2019
Q3 | – | Sell |
-53,667
| Closed | -$6.72M | – | 784 |
|
2019
Q2 | $6.72M | Sell |
53,667
-29,908
| -36% | -$3.74M | 0.02% | 318 |
|
2019
Q1 | $9.21M | Buy |
83,575
+4,965
| +6% | +$547K | 0.03% | 262 |
|
2018
Q4 | $7.56M | Sell |
78,610
-10,611
| -12% | -$1.02M | 0.03% | 272 |
|
2018
Q3 | $11M | Buy |
89,221
+5,212
| +6% | +$644K | 0.04% | 244 |
|
2018
Q2 | $8.34M | Buy |
84,009
+64,000
| +320% | +$6.35M | 0.03% | 301 |
|
2018
Q1 | $1.77M | Buy |
20,009
+17,855
| +829% | +$1.58M | 0.01% | 556 |
|
2017
Q4 | $212K | Buy |
+2,154
| New | +$212K | ﹤0.01% | 689 |
|